ProAssurance Corporation
NYSE:PRAInsurance - Property & Casualty
+$0.00 today
- Market cap
- $1.29B
- Beta
- 0.04
- P/E (TTM)
- 19.4
- EPS (TTM)
- $1.27
Volume 0.00M
Average 0.93M
PRA Sales of Investments
Cash received from selling or redeeming investments.
ProAssurance CorporationNYSE: PRA
Sales of Investments · Q1 FY2026 · quarter ended Mar 2026
Sales of investments dips below year-ago levels
Q1 FY2026 sales of investments of $245.13M fell 19.6% year over year, behind the +3.1% change in trailing-twelve-month sales of investments. Sequentially, it rose 11.2% from the prior quarter. Over 3 fiscal years it compounded at +16.2% a year.
Context
- Sales of investments amounted to 82.6% of revenue in FY2025, up 13.6 pp from a year earlier.
- Sales of investments increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from -19.6% toward the trailing-twelve-month pace of +3.1%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Sales of Investments history
USD · from the cash flow
- Latest · FY2025
- 907.45M USD
- Year-over-year change
- +16.6%
- 4-year CAGR
- -9.5%
| Period | Period end | Sales of Investments | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 907.45M | +16.6% |
| FY2024 | 2024-12-31 | 778.45M | +32.8% |
| FY2023 | 2023-12-31 | 586.18M | +1.5% |
| FY2022 | 2022-12-31 | 577.65M | -57.3% |
| FY2021 | 2021-12-31 | 1.35B | — |
Sales of Investments vs competitors
How PRA compares with its peers on the latest reported figures
- PRA's LTM Mar 2026 sales of investments of $847.82M is the 3rd largest of the 11 companies compared; the peer median is $294.53M.
- Its year-over-year change of +3.1% is the 5th highest of 10, against a peer median of -22.0%.
- Sales of investments amounts to 78.6% of revenue for PRA, versus a peer median of 43.7%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $11.32B | -28.6% | +32.9% | 208.5% | |
| LTM Mar 2026 | $924.95M | -22.0% | +14.6% | 324.6% | |
| LTM Mar 2026 | $847.82M | +3.1% | +16.2% | 78.6% | |
| LTM Mar 2026 | $513.78M | +577.4% | +43.4% | 70.0% | |
| LTM Mar 2026 | $370.86M | +2071.1% | -58.9% | 29.2% | |
| LTM Mar 2026 | $356.2M | +32.2% | +23.3% | 56.2% | |
| LTM Mar 2026 | $232.86M | -59.1% | +2.1% | 31.3% | |
| LTM Mar 2025 | $103.25M | -76.2% | -50.5% | 248.3% | |
| LTM Mar 2026 | $70.7M | +13.5% | +19.2% | 4.5% | |
| LTM Mar 2026 | $57.08M | -85.1% | +169.4% | 21.6% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding PRA) | $294.53M | -22.0% | +19.2% | 43.7% | |
Competitors are the stored peer set for PRA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 144.12M | (402K) | (38.6M) | 52.74M | 50.92M |
| Depreciation & Amortization | 37.25M | 38.06M | 26.02M | 17.75M | 13.69M |
| Deferred Income Tax | 1.32M | (6.62M) | (1.77M) | 12.82M | 16.79M |
| Stock-Based Compensation | 4.39M | 4.83M | 5.25M | 6.2M | 7.85M |
| Change in Working Capital | 12.9M | (124.5M) | (81.94M) | (95.96M) | (126.13M) |
| Accounts Receivables | 71.21M | (5M) | 10.53M | 6.67M | 605K |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | 0 | 0 | 0 | 0 | 0 |
| Other Working Capital | (58.3M) | (119.5M) | (92.47M) | (102.63M) | (126.74M) |
| Other Non-Cash Items | (126.01M) | 58.79M | 41.17M | (4.28M) | 11.27M |
| Operating Cash Flow | 73.97M | (29.84M) | (49.89M) | (10.72M) | (25.62M) |
| Capital Expenditures | (3.84M) | (4.35M) | (4.79M) | (9.02M) | (3.6M) |
| Acquisitions (Net) | 0 | 48.62M | 0 | 39.68M | 19.38M |
| Purchases of Investments | (1.51B) | (681.25M) | (464.94M) | (798.44M) | (924.07M) |
| Sales of Investments | 1.35B | 577.65M | 586.18M | 778.45M | 907.45M |
| Other Investing Activities | 78.31M | (2.66M) | 24.69M | 0 | 20.27M |
| Investing Cash Flow | (85.53M) | (62M) | 141.14M | 10.67M | 19.44M |
| Debt Repayment | (36.11M) | 0 | 0 | (4.69M) | (6.25M) |
| Common Stock Issued | 10.38M | 0 | 0 | 8K | 0 |
| Common Stock Repurchased | (10.38M) | (3.25M) | (50.49M) | 0 | 0 |
| Dividends Paid | (10.76M) | (10.77M) | (5.38M) | 0 | 0 |
| Other Financing Activities | (3.38M) | (7.79M) | 552K | (6.3M) | (5.95M) |
| Financing Cash Flow | (60.62M) | (21.81M) | (55.32M) | (10.97M) | (12.2M) |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | (72.18M) | (113.64M) | 35.94M | (11.02M) | (18.39M) |
| Free Cash Flow | 70.13M | (34.19M) | (54.68M) | (19.73M) | (29.22M) |
ProAssurance Corporation
NYSE:PRA
Intrinsic Alpha fair value
Locked
Current Price
$25.00
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.